The decrease in EPS suggests that ProKidney's profitability has declined, which could negatively impact investor sentiment and the stock price in the short term. However, the substantial cash reserves might provide some cushion against the negative earnings impact, indicating the company's ability to sustain operations and invest in growth. The mixed nature of this report suggests a cautious outlook for the stock.